<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="systematic-review" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2022.1095361</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Systematic Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Effectiveness of transverse tibial bone transport in treatment of diabetic foot ulcer: A systematic review and meta-analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Xing-xi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiu</surname>
<given-names>Zheng-zhong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Gui-chun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Ji-yuan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shu</surname>
<given-names>Long-jun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Zhong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Han</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zou</surname>
<given-names>Qing-feng</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhou</surname>
<given-names>Quan</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2094145"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Orthopedics and Trauma, The Affiliated Hospital of Yunnan University (The Second People&#x2019;s Hospital of Yunnan Province, The Eye Hospital of Yunnan Province)</institution>, <addr-line>Kunming, Yunnan</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Orthopedics, The First People&#x2019;s Hospital of Dali City</institution>, <addr-line>Dali</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Western Yunnan University of Applied Science and Technology</institution>, <addr-line>Dali</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Jing Wu, Xiangya Hospital, Central South University, China</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Joanna K. Filipowska, City of Hope National Medical Center, United States; Siliang Xue, Sichuan University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Qing-feng Zou, <email xlink:href="mailto:742427149@qq.com">742427149@qq.com</email>; Quan Zhou, <email xlink:href="mailto:zhouquandali@yeah.net">zhouquandali@yeah.net</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Clinical Diabetes, a section of the journal Frontiers in Endocrinology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>01</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>1095361</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>12</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Hu, Xiu, Li, Zhang, Shu, Chen, Li, Zou and Zhou</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Hu, Xiu, Li, Zhang, Shu, Chen, Li, Zou and Zhou</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Diabetic foot ulcerations (DFUs) are a common but highly morbid complication of long-standing diabetes, carrying high rates of associated major amputation and mortality. Transverse tibial bone transport (TTT) has recently been applied for treatment of DFUs with the aim of accelerating wound healing. This study was performed to evaluate the effectiveness and safety of TTT in patients with DFUs.</p>
</sec>
<sec>
<title>Methods</title>
<p>Two authors independently retrieved the platforms of PubMed, Embase and CENTRAL, to identify studies associated with treatment of DFUs with TTT. Quantitative meta-analyses were performed to pool all available outcomes about the effectiveness and complications of TTT operation, with fixed- (I<sup>2</sup>&lt;50%) or random-effect (I<sup>2</sup>&gt;50%) model according to I<sup>2</sup>.</p>
</sec>
<sec>
<title>Results</title>
<p>A total of 7 studies, involving 818 participants, were included, with 661 participants treated with TTT operation. The pooled healing rate and limb salvage rate were 0.96 (95%CI: 0.93~0.98) and 0.98 (95%CI: 0.95~1.00) respectively after treatment with TTT. The pooled mean healing time was 15.03 (95%CI: 9.05~21.00) months. When compared with the pre-operative baseline values, the ankle-brachial index (ABI, MD: 0.23; 95%CI: 0.03~0.44; p&lt;0.001), skin temperature (MD: 1.56; 95%CI: 0.30~2.81; p&lt;0.001), and visual analogue scale (VAS, MD: 3.70; 95%CI: 1.97~5.44; p&lt;0.001) were significantly improved at the final follow-up. When compared with non-TTT group, the TTT group was associated with higher healing rate (OR: 10.43; 95%CI: 3.96~27.43; p&lt;0.001) and limb salvage rate (OR: 9.65; 95%CI: 3.30~28.20; p&lt;0.001). Concerning the complications of the TTT process, the pooled risks of fracture at transportation site and pin-site infection were 0.02 (95%CI: 0.00~0.04) and 0.08 (95%CI: 0.00~0.22), respectively; and the DFU recurrence rate in TTT group was significantly lowered comparing to that of the non-TTT group (RR: 0.18; 95%CI: 0.06~0.49; p=0.001).</p>
</sec>
<sec>
<title>Conclusions</title>
<p>TTT operation was associated with high healing rate and limb salvage rate, and could significantly improve the ABI, skin temperature, and VAS after operation. When compared with the control group, TTT group provided significantly higher healing rate and limb salvage rate. However, TTT operation should be conducted with caution concerning the incidences of fracture at tibia, infection at pin channels and necrosis of skin overlying the anterior tibia.</p>
</sec>
</abstract>
<kwd-group>
<kwd>transverse tibial bone transport</kwd>
<kwd>meta-analysis</kwd>
<kwd>ulceration healing</kwd>
<kwd>neovascularization</kwd>
<kwd>diabetic foot ulceration</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="30"/>
<page-count count="12"/>
<word-count count="4942"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Diabetes has gradually emerged as one of the most globally challenging chronic diseases, its prevalence has increased significantly over the past few decades, resulting in disabling and costly complications, life-threatening conditions, and reducing life expectancy (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). The IDF (International Diabetes Federation) Diabetes Atlas, 10th edition, showed that by 2021, 1 in 10 adults worldwide will have diabetes and the number of people with diabetes will continue to increase rapidly in the future (<xref ref-type="bibr" rid="B1">1</xref>). Diabetic foot is an infection, ulceration and deep tissue destruction of the foot caused by neuropathy and vascular disease of the lower limbs in diabetic patients (<xref ref-type="bibr" rid="B3">3</xref>). About 19% - 34% of people with diabetes are likely to have diabetic foot ulcers (DFUs) in their lifetime (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). DFU is a common but severely prevalent complication of long-term diabetes with high rates of associated amputation and mortality (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B7">7</xref>). The global burden of DFUs is steadily increasing as the global prevalence of diabetes rises (<xref ref-type="bibr" rid="B8">8</xref>). It is well known that the outcomes of diabetes and DFUs depend heavily on the social determinants of health, with worse outcomes for ethnic minorities and socio-economically disadvantaged groups (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>Tibial bone transverse transport (TTT) is an extension of the Ilizarov technique (<xref ref-type="bibr" rid="B9">9</xref>). Being different from the longitudinal transport of the osteotomy segment according to the Ilizarov external fixation technique, this procedure involves transverse traction of the tibial osteotomy segment. The primary goal of TTT is not osteogenesis, but local vascular tissue regeneration (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). Originated in the law of &#x201c;stress-tension&#x201d;, continuous distraction of the tibial cortex promotes cellular metabolism, accelerates tissue regeneration, reestablishes microcirculation and restores blood oxygen to the lower limbs. This technique is mainly used for the treatment of chronic ischaemic diseases of the lower extremities, at this stage (<xref ref-type="bibr" rid="B12">12</xref>).</p>
<p>China&#x2019;s Qu et&#xa0;al. (<xref ref-type="bibr" rid="B13">13</xref>) firstly applied TTT to clinical practice in China, which not only introduced TTT to China, but also initiated the exploration of TTT among Chinese scholars. Ou et&#xa0;al. (<xref ref-type="bibr" rid="B3">3</xref>) found that TTT can improve blood circulation in the affected limb, promote wound healing in diabetic feet, reduce amputation rates, and significantly increase the expression of early serum angiogenic factors, which may contribute to the mechanism of accelerated healing of diabetic foot wounds. Additionally, Nie et&#xa0;al. (<xref ref-type="bibr" rid="B14">14</xref>) found that TTT is an effective treatment for refractory non-diabetic lower extremity ulcers compared to conventional surgery.</p>
<p>To our knowledge, TTT has been used many times in recent years to treat diabetic foot. With the continuous development of orthopaedic procedures, the use of TTT for diabetic foot has become more and more mature, and several clinical studies have shown that this method has significant efficacy in treating diabetic foot with less adverse effects (<xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B18">18</xref>), but there is still no relevant publication on evidence-based rationale. Accordingly, we conducted this quantitative meta-analysis to thoroughly evaluate the clinical efficacy and safety of TTT in the treatment protocols of DFUs.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<p>This systematic review and meta-analysis was performed according to the guideline outlined in Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) statement. The PRISMA checklist is presented in <xref ref-type="supplementary-material" rid="SM1">
<bold>Appendix 1</bold>
</xref>.</p>
<sec id="s2_1">
<title>Data source and study searching</title>
<p>Two authors retrieved the electronic databases, including PubMed, Embase and the Cochrane Central Register of Controlled Trials (CENTRAL) from the inception dates to Nov. 2022, independently. The keywords used for study searching include &#x201c;diabetic foot ulcer&#x201d;, &#x201c;diabetic foot&#x201d;, &#x201c;transverse tibial bone transport&#x201d;, and so on. We combined the subject terms and free terms together to ensure full coverage of the potential eligible studies. The list of the searching strategies of three databases is available in <xref ref-type="supplementary-material" rid="SM3"><bold>Appendix 2</bold></xref>. The related studies in the references list of each included study were also hand-searched and included for analysis.</p>
</sec>
<sec id="s2_2">
<title>Inclusion and exclusion criteria</title>
<p>After exporting the literature records from the databases, two authors screened all of them one by one to identify eligible studies, according to the inclusion criteria as follows: (1) patients were diagnosed with DFU (type-I or -II diabetes)DFU; (2) patients were operated with TTT on the DFU affected leg; (3) studies observed the treatment outcomes of the TTT surgery, such as healing time, healing rate, ABI, skin temperature, VAS pain scale, complications, and so on; (4) clinical studies designed as randomized controlled trials (RCTs), cohort studies, case-control studies, or case series. The publication language was restricted in English.</p>
<p>Studies would be excluded when meeting the following criteria: (1) duplicated studies; (2) patients operated for foot ulcer derived from non-diabetic diseases (such as occlusive vascular disease); (3) studies designed as case report, literature review, systematic review/meta analysis and letter to editors.</p>
</sec>
<sec id="s2_3">
<title>Study screening</title>
<p>The initially retrieved records were imported into EndNote version 20.2.1 (Clarivate Analytics, Philadelphia, USA), and the duplicated studies were merged together. After then, we screened the title and abstract of each record to assess the eligibility and excluded the obviously non-related studies. The full-text of the remained studies were finally reviewed to identify the final eligible studies. The whole process of study screening was conducted by two authors independently, according to the inclusion and exclusion criteria.</p>
</sec>
<sec id="s2_4">
<title>Data extraction and quality assessment</title>
<p>According to the PICOS principle, we perused all of the included studies, and extracted the items as follows: (1) Participants (P): patients number, drop-out patients, age, sex, body mass index (BMI), type of diabetes, lengths of diabetes history and DFU history, ulceration grade, ulceration area, glycosylated hemoglobin (HbA1C), and ankle-brachial index (ABI); (2) Interventions (I): detailed treatment protocol, perioperative management, anesthesia method, site of TTT, bone window size, fixations of external fixator and bone block, and detailed bone transportation protocol; (3) Comparisons (C): when a control group was set, the information about the treatment process was extracted; (4) Outcomes (O): healing rate, healing time, limb salvage rate, ABI, skin temperature, visual analogue scale (VAS) pain scale, and complications such as fracture at transportation site, pin-site infection, DFU recurrence; (5) Study (S): lead author&#x2019;s name, publication year, country, study period, study design, and follow-up period. The process of data extraction was conducted according to the checklist of data collection which was proposed by the Cochrane Collaboration. The data were extracted by two individual reviewers independently, and cross-checked.</p>
<p>The quality of the RCTs, case-control studies, case series was assessed using the Cochrane Collaboration tool for assessing risk of bias, Newcastle-Ottawa scale (NOS), and JBI Meta-Analysis of Statistics, Assessment, and Review Instrument (JBI-MAStARI) scale. This process was performed by two authors independently, and the disagreement was solved by the third author.</p>
</sec>
<sec id="s2_5">
<title>Statistical analysis</title>
<p>(1) For outcomes such as healing rate, limb salvage rate, fracture incidence at transport site, and pin-site infection risk in the TTT group, single proportional meta-analyses were performed to calculate the pooled proportions, with the &#x201c;PRAW&#x201d; model; (2) for outcomes such as healing time of TTT group, meta-analyses of single-group continuous data were performed to calculate the pooled mean values, with the &#x201c;MRAW&#x201d; model; (3) for comparisons between pre-operative and post-operative ABI, skin temperature, and VAS, meta-analyses of continuous data were conducted, with effect size of mean difference (MD); (4) for comparisons of healing rate and limb salvage rate between TTT and control groups, meta-analyses of binary data were performed with effect size of odds ratio (OR); (5) for comparison of the DFU recurrence risk between TTT and control group, meta-analyses of binary data were performed with effect size of risk ratio (RR).</p>
<p>The heterogeneity was tested with I<sup>2</sup>, and random- or fixed-effect model would be employed, when presenting with or without significant heterogeneity (I<sup>2</sup>&gt;50%). Z test was used to test the statistical significance of the pooled results. Funnel plot and Egger&#x2019;s/Begg&#x2019;s tests (p&lt;0.1 and p&lt;0.05 indicate significant publication bias for Egger&#x2019;s and Begg&#x2019;s tests, respectively) were used to detect the risk of publication bias when five or more studies were included in a meta-analysis. If significant publication bias was detected, non-parameter trim-and-fill method was used to adjust the bias. Sensitivity analyses were performed when significant heterogeneity was evident in meta-analyses with five or more studies. The statistical significance was defined as a two-side P value of less than 0.05. The statistical procedures were completed using R 4.1.3 for Windows (R Foundation for Statistical Computing, Vienna, Austria).</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>Study searching and selecting</title>
<p>The flowchart of the study searching and selecting is presented in the <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>. In total, 99 articles were retrieved through databases and manual searching. The titles/abstracts of 72 articles were reviewed after removing 27 duplicates. A total of 35 studies not related to this topic were excluded after reviewing the titles and abstracts. Then, the full-text of 37 studies were screening for final eligibility. A total of 7 studies (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>) were finally included for analysis.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>PRISMA flowchart of study searching and selecting.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1095361-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>Study characteristics of the included studies</title>
<p>Summary of the characteristics of the eligible studies is shown in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. All of the studies were published after 2019, in China. The study designs include single-arm RCT (n=1) (<xref ref-type="bibr" rid="B3">3</xref>), case-control study (n=4) (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>), and case-series study (n=2) (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B17">17</xref>). A total of 818 participants were included, with 661 participants treated with TTT operation. The mean age was ranged between 40.0 &#xb1; 11.0 to 70.4 &#xb1; 6.0 years, and the male percentage was ranged between 52.6% to 83.3%. The type of diabetes was reported in 4 studies (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B19">19</xref>), with an overall percentage of type II diabetes of 98.91% (type I: 8; type II: 727). Data about Wagner and TEXAS ulceration grades were reported in 4 (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B20">20</xref>) and 3 (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B19">19</xref>) studies, respectively. In TTT and non-TTT groups, 3 and 2 patients were lost to follow-up respectively. The quality assessment result of the studies is presented in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref>.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Summary of the study characteristics in the eligible studies.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Study ID</th>
<th valign="middle" align="center">Country</th>
<th valign="middle" align="center">Study period</th>
<th valign="middle" align="center">Study design</th>
<th valign="middle" align="center">Groups</th>
<th valign="middle" align="center">N</th>
<th valign="middle" align="center">Age</th>
<th valign="middle" align="center">Male%</th>
<th valign="middle" align="center">BMI</th>
<th valign="middle" align="center">Diabetes types (I/II)</th>
<th valign="middle" align="center">Length of diabetes</th>
<th valign="middle" align="center">Length of DFU</th>
<th valign="middle" align="center">Ulceration grade</th>
<th valign="middle" align="center">Ulceration area (cm2)</th>
<th valign="middle" align="center">HbA1C (%)</th>
<th valign="middle" align="center">ABI</th>
<th valign="middle" align="center">Follow-up</th>
<th valign="middle" align="center">Drop-out</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Fan ZQ, 2020 (<xref ref-type="bibr" rid="B15">15</xref>)</td>
<td valign="middle" align="left">China</td>
<td valign="middle" align="center">2015.03-2018.03</td>
<td valign="middle" align="left">case series</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="center">30</td>
<td valign="middle" align="left">40.0&#xb1;11.0</td>
<td valign="middle" align="center">70.0</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">17.5y</td>
<td valign="middle" align="left">Wagner 2/3/4: 8/16/6</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="center">16.5m</td>
<td valign="middle" align="center">0</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Ding XF, 2022 (<xref ref-type="bibr" rid="B16">16</xref>)</td>
<td valign="middle" rowspan="2" align="left">China</td>
<td valign="middle" rowspan="2" align="center">2016.11-2019.11</td>
<td valign="middle" rowspan="2" align="left">case-control study</td>
<td valign="middle" align="left">TTT<sub>1</sub>
</td>
<td valign="middle" align="center">115</td>
<td valign="middle" align="left">70.4&#xb1;6.0</td>
<td valign="middle" align="center">67.8</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">2/113</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">3.8&#xb1;0.4m</td>
<td valign="middle" align="left">TEXAS 3D/4D: 26/89</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">0.29&#xb1;0.30</td>
<td valign="middle" rowspan="2" align="center">12.6m</td>
<td valign="middle" align="center">0</td>
</tr>
<tr>
<td valign="middle" align="left">TTT<sub>2</sub>
</td>
<td valign="middle" align="center">128</td>
<td valign="middle" align="left">68.9&#xb1;8.0</td>
<td valign="middle" align="center">69.5</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">2/126</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">4.3&#xb1;0.1m</td>
<td valign="middle" align="left">TEXAS 3D/4D: 32/96</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">0.32&#xb1;0.31</td>
<td valign="middle" align="center">0</td>
</tr>
<tr>
<td valign="middle" align="left">Ou SJ, 2022 (<xref ref-type="bibr" rid="B3">3</xref>)</td>
<td valign="middle" align="left">China</td>
<td valign="middle" align="center">2017.01-2019.10</td>
<td valign="middle" align="left">single-arm Quasi-RCT</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="center">18</td>
<td valign="middle" align="left">67.0&#xb1;11.9</td>
<td valign="middle" align="center">52.6</td>
<td valign="middle" align="left">21.7&#xb1;2.5</td>
<td valign="middle" align="left">0/18</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">median: 1</td>
<td valign="middle" align="left">Wagner 4: 18</td>
<td valign="middle" align="left">median: 2.0</td>
<td valign="middle" align="left">7.1&#xb1;0.5</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="center">14.0m</td>
<td valign="middle" align="center">1</td>
</tr>
<tr>
<td valign="middle" align="left">Yuan YS, 2021 (<xref ref-type="bibr" rid="B17">17</xref>)</td>
<td valign="middle" align="left">China</td>
<td valign="middle" align="center">2016.01-2.19.10</td>
<td valign="middle" align="left">case series</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="center">201</td>
<td valign="middle" align="left">68.3&#xb1;7.1</td>
<td valign="middle" align="center">53.2</td>
<td valign="middle" align="left">Median:23.5</td>
<td valign="middle" align="left">0/201</td>
<td valign="middle" align="left">median: 93m</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">TEXAS 2C/2D/3D: 139/36/26</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">Median: 10.0</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="center">12m</td>
<td valign="middle" align="center">0</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Zeng ZS, 2019 (<xref ref-type="bibr" rid="B18">18</xref>)</td>
<td valign="middle" rowspan="2" align="left">China</td>
<td valign="middle" rowspan="2" align="center">2015.12-2017.02</td>
<td valign="middle" rowspan="2" align="left">case-control study</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" rowspan="2" align="center">12*</td>
<td valign="middle" rowspan="2" align="left">55.0&#xb1;7.0</td>
<td valign="middle" rowspan="2" align="center">83.3</td>
<td valign="middle" rowspan="2" align="left">NA</td>
<td valign="middle" rowspan="2" align="left">NA</td>
<td valign="middle" rowspan="2" align="left">NA</td>
<td valign="middle" rowspan="2" align="left">NA</td>
<td valign="middle" rowspan="2" align="left">Wagner 3/4:7/5</td>
<td valign="middle" rowspan="2" align="left">&lt;25cm<sup>2</sup>:7;&gt;25cm<sup>2</sup>:5</td>
<td valign="middle" rowspan="2" align="left">NA</td>
<td valign="middle" rowspan="2" align="left">NA</td>
<td valign="middle" rowspan="2" align="center">8w</td>
<td valign="middle" rowspan="2" align="center">0</td>
</tr>
<tr>
<td valign="middle" align="left">non-TTT</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Chen Y, 2019 (<xref ref-type="bibr" rid="B19">19</xref>)</td>
<td valign="middle" rowspan="2" align="left">China</td>
<td valign="middle" rowspan="2" align="center">2014.07-2017.03</td>
<td valign="middle" rowspan="2" align="left">case-control study</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="center">136</td>
<td valign="middle" align="left">61.0&#xb1;10.0</td>
<td valign="middle" align="center">70.0</td>
<td valign="middle" align="left">23.0&#xb1;3.2</td>
<td valign="middle" align="left">2/134</td>
<td valign="middle" align="left">21&#xb1;9y</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">TEXAS 2B/2C/2D/3B/3C/3D: 5/7/35/6/11/72</td>
<td valign="middle" align="left">44&#xb1;10</td>
<td valign="middle" align="left">9.7&#xb1;3.7</td>
<td valign="middle" align="left">0.37&#xb1;0.06</td>
<td valign="middle" rowspan="2" align="center">2y</td>
<td valign="middle" align="center">1</td>
</tr>
<tr>
<td valign="middle" align="left">non-TTT</td>
<td valign="middle" align="center">137</td>
<td valign="middle" align="left">60.0&#xb1;11.0</td>
<td valign="middle" align="center">64.0</td>
<td valign="middle" align="left">23.0&#xb1;3.4</td>
<td valign="middle" align="left">2/135</td>
<td valign="middle" align="left">20&#xb1;7y</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">TEXAS 2B/2C/2D/3B/3C/3D: 11/10/37/7/8/64</td>
<td valign="middle" align="left">41&#xb1;9</td>
<td valign="middle" align="left">9.5&#xb1;3.2</td>
<td valign="middle" align="left">0.35&#xb1;0.05</td>
<td valign="middle" align="center">2</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Fan ZQ, 2022 (<xref ref-type="bibr" rid="B20">20</xref>)</td>
<td valign="middle" rowspan="2" align="left">China</td>
<td valign="middle" rowspan="2" align="center">2017.03-2019.03</td>
<td valign="middle" rowspan="2" align="left">case-control study</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="center">21</td>
<td valign="middle" align="left">Median: 52(42-65)</td>
<td valign="middle" align="center">76.2</td>
<td valign="middle" align="left">23.5&#xb1;4.5</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">median:14.5y</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">Wagner 2/3/4: 2/14/4</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">0.45&#xb1;0.13</td>
<td valign="middle" align="center">&gt;1y</td>
<td valign="middle" align="center">1</td>
</tr>
<tr>
<td valign="middle" align="left">Healthy control</td>
<td valign="middle" align="center">20</td>
<td valign="middle" align="left">Median: 51(40-64)</td>
<td valign="middle" align="center">75.0</td>
<td valign="middle" align="left">23.7&#xb1;6.5</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="center">&#x2013;</td>
<td valign="middle" align="center">0</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>N, patients number; TTT, Transverse Tibial Bone Transport; ABI, ankle brachial index; BMI, body mass index; HbA1C, glycosylated hemoglobin; DFU, diabetic foot ulcer; NA, not available. *a total of 12 patients were included in this study, and the operated leg was matched with the contralateral leg in analysis.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_3">
<title>Detailed operation process</title>
<p>The detailed operation process is summarized in <xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>. A routine debridement on the ulceration site was performed at the same time in most of the studies (<xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Vacuum sealing drainage (VSD) and antibiotic bone cement (ABC) were applied at ulceration site in 2 (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B20">20</xref>) and 1 (<xref ref-type="bibr" rid="B16">16</xref>) studies, respectively. In the peri-operative period, the managements mainly include the following four aspect: (1) antibiotics treatment according to drug sensitivity test; (2) debridement and drainage; (3) blood sugar controlling; and (4) dressing changing and disinfection. The operation was performed under general anesthesia (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B20">20</xref>), nerve block anesthesia (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B19">19</xref>), or lumbar anesthesia (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). The transportation site mainly located at the anteromedial area of the tibia, but the heights of the bone window were divergent among these studies. In Fan et&#xa0;al. (<xref ref-type="bibr" rid="B15">15</xref>), bone window was located at 10-20 cm below knee as they stated. In Ding et&#xa0;al. (<xref ref-type="bibr" rid="B16">16</xref>), Yuan et&#xa0;al. (<xref ref-type="bibr" rid="B17">17</xref>), and Chen et&#xa0;al. (<xref ref-type="bibr" rid="B19">19</xref>), bone window was located at the proximal tibia. In Ou et&#xa0;al. (<xref ref-type="bibr" rid="B3">3</xref>) and Zeng et&#xa0;al. (<xref ref-type="bibr" rid="B18">18</xref>), transportation site was located at middle or distal tibia. The size of bone window was reported in three studies (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>), with different sizes. Generally, two individual pins were applied at the bone block to transport it and the tibia shaft to fixing the external fixator, respectively. All of the studies initiated the transportation at the time of 3-5 days post-operatively. Two different protocols to transport the bone block were reported: (1) 1mm per day for 14 days (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B20">20</xref>); (2) 0.25 mm per 6h for 14 days (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Three different protocols to reset the bone block were reported: (1) 1mm per day for 14 days (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B20">20</xref>); (2) 0.25 mm per 6h for 14 days (<xref ref-type="bibr" rid="B19">19</xref>); (3) 2 mm per day for 7 days (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>The detailed operation process of the included studies.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="middle" align="left">Study ID</th>
<th valign="middle" align="center">Treatment groups</th>
<th valign="middle" align="center">Detailed treatment protocol</th>
<th valign="middle" align="center">Perioperative management</th>
<th valign="middle" align="center">anesthesia method</th>
<th valign="middle" align="center">Transportation site</th>
<th valign="middle" align="center">Bone window size</th>
<th valign="middle" align="center">External fixation details</th>
<th valign="middle" align="center">Bone transportation protocol</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="middle" align="left">Fan ZQ, 2020 (<xref ref-type="bibr" rid="B15">15</xref>)</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="left">TTT+ debridement</td>
<td valign="middle" align="left">1.continuous closed NPD (n = 12);2.antibiotics according to drug sensitivity test;3.wound dressings changing</td>
<td valign="middle" align="left">general anesthesiaor lumbar anesthesia</td>
<td valign="middle" align="left">medial tibial cortex about 10 to 20 cm below knee</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">1.Fixation: 2 half nails;2.Transportation: 2 half nails</td>
<td valign="middle" align="left">began time: 3 to 5 days;transport: 1mm per day for 14 days;reset: 1 mm per day in the reverse direction for 14 days</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Ding XF, 2022 (<xref ref-type="bibr" rid="B16">16</xref>)</td>
<td valign="middle" align="left">TTT<sub>1</sub>
</td>
<td valign="middle" align="left">TTT+ debridement</td>
<td valign="middle" rowspan="2" align="left">1.emergency debridement, drainage, and foot care;2.antibiotics;3.nail passageway disinfection;4.blood sugar controlling</td>
<td valign="middle" rowspan="2" align="left">nerve block anaesthesia</td>
<td valign="middle" rowspan="2" align="left">anteromedial area of the proximal tibia</td>
<td valign="middle" rowspan="2" align="left">NA</td>
<td valign="middle" rowspan="2" align="left">1.Fixation: two 4.0 Steinmann pins;2.Transportation: two 3.0 Steinmann pins</td>
<td valign="middle" rowspan="2" align="left">began time: 3 days;transport: 1mm per day for 14 daysReset: 2mm per day in the reverse direction for 7days</td>
</tr>
<tr>
<td valign="middle" align="left">TTT<sub>2</sub>
</td>
<td valign="middle" align="left">TTT+ABC</td>
</tr>
<tr>
<td valign="middle" align="left">Ou SJ, 2022 (<xref ref-type="bibr" rid="B3">3</xref>)</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="left">1.blood sugar /lipids /pressure, and hypoproteinemia controlling;2.wound dressing changing and disinfection</td>
<td valign="middle" align="left">nerve block anesthesia</td>
<td valign="middle" align="left">anterior medial part of the middle and lower leg</td>
<td valign="middle" align="left">7*1.8*1.5 cm</td>
<td valign="middle" align="left">1.Fixation: two pins;2.Transportation: two pins</td>
<td valign="middle" align="left">1.began time: 4 days;2.transport: 1mm per day for 14 days3.Reset: 2mm per day in the reverse direction for 7days</td>
</tr>
<tr>
<td valign="middle" align="left">Yuan YS, 2021 (<xref ref-type="bibr" rid="B17">17</xref>)</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="left">mTTT+ debridement+VSD</td>
<td valign="middle" align="left">1.IV antibiotics based on drug susceptibility testing;2.complete debridement and removing infected bone surgically, antibiotic bone cement implantation;3. continuous closed negative pressure drainage;4.blood glucose controlling;5.dressing changing and disinfection</td>
<td valign="middle" align="left">nerve block anaesthesia</td>
<td valign="middle" align="left">anteromedial area of the proximal tibia</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">1.Fixation: two 4.0 Steinmann pins;2.Transportation: two 3.0 Steinmann pins</td>
<td valign="middle" align="left">1.began time: 3 days;2.transport: 0.25 mm per 6h for 14days;3.reset: 2 mm per day for 7 days</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Zeng ZS, 2019 (<xref ref-type="bibr" rid="B18">18</xref>)</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="left">TTT-foot</td>
<td valign="middle" rowspan="2" align="left">NA</td>
<td valign="middle" rowspan="2" align="left">NA</td>
<td valign="middle" rowspan="2" align="left">middle of the tibia</td>
<td valign="middle" rowspan="2" align="left">3.5*1.5cm (two windows)</td>
<td valign="middle" rowspan="2" align="left">1.Transportation: A 60*4-mm Shashi needle on each window2.Fixation: two 120*4-mm needles</td>
<td valign="middle" rowspan="2" align="left">NA</td>
</tr>
<tr>
<td valign="middle" align="left">non-TTT</td>
<td valign="middle" align="left">Contralateral foot</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Chen Y, 2019 (<xref ref-type="bibr" rid="B19">19</xref>)</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="left">TTT+ debridement</td>
<td valign="middle" rowspan="2" align="left">1.antibiotics based on drug susceptibility testing;2.Standard daily wound care and off-loading casts;</td>
<td valign="middle" rowspan="2" align="left">spinal anesthesia or femoral nerve block</td>
<td valign="middle" rowspan="2" align="left">located below the tibial tuberosity</td>
<td valign="middle" rowspan="2" align="left">5*1.5cm</td>
<td valign="middle" rowspan="2" align="left">1.Fixation: two pins;2.Transportation: two pins</td>
<td valign="middle" rowspan="2" align="left">1.began time: 4 days;2.transport: 0.25 mm per 6h for 14 days;3.reset: 0.25 mm per 6h for 14 days</td>
</tr>
<tr>
<td valign="middle" align="left">non-TTT</td>
<td valign="middle" align="left">standard surgical treatments*</td>
</tr>
<tr>
<td valign="middle" rowspan="2" align="left">Fan ZQ, 2022 (<xref ref-type="bibr" rid="B20">20</xref>)</td>
<td valign="middle" align="left">TTT</td>
<td valign="middle" align="left">TTT+ debridement+VSD</td>
<td valign="middle" align="left">1.blood glucose controlling;2.necrotic tissue debridement;3.antibiotics based on drug sensitivity testing</td>
<td valign="middle" align="left">general or lumbar anesthesia</td>
<td valign="middle" align="left">medial tibial cortex, approximately 10&#x2013;20&#xa0;cm distal to knee joint</td>
<td valign="middle" align="left">NA</td>
<td valign="middle" align="left">1.Fixation: two half-nails;2.Transportation: two half-nails</td>
<td valign="middle" align="left">1.began time: 3-5 days;2.transport: 1 mm per day for 14 days;3.reset: 1 mm per day for 14 days</td>
</tr>
<tr>
<td valign="middle" align="left">Healthy control</td>
<td valign="middle" align="left">Healthy control without any treatment</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
<td valign="middle" align="left">&#x2013;</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>*standard surgical treatments include: debridement, revascularization, local or free flap or skin equivalent, or graft reconstruction along with negative pressure wound therapy. TTT, Transverse Tibial Bone Transport; mTTT, modified Transverse Tibial Bone Transport; NA, not available; NPD, negative-pressure drainage; ABC, antibiotics bone cement; VSD, vacuum sealing drainage.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_4" sec-type="results">
<title>Results of quantitative meta-analyses</title>
<p>
<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref> shows the treatment outcomes of the TTT operation at the final follow-up. The pooled healing rate was 0.96 (95% confidence interval [95%CI]: 0.93~0.98; see <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>), using a fixed-effect model. The pooled limb salvage rate was as high as 0.98 (95%CI: 0.95~1.00; see <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>) after treatment with TTT. The pooled mean healing time was 15.03 (95%CI: 9.05~21.00; see <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>) months.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Forest plots for the meta-analyses of healing rate <bold>(A)</bold>, limb salvage rate <bold>(B)</bold> and mean healing time <bold>(C)</bold> in TTT group. Fixed-effect model was applied for healing rate, while random-effect model was applied for limb salvage and healing time. TTT, transverse tibia bone transportation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1095361-g002.tif"/>
</fig>
<p>When compared with the pre-operative baseline values, the ABI (random-effect model; MD: 0.23; 95%CI: 0.03~0.44; p&lt;0.001; see <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>), skin temperature (random-effect model; MD: 1.56; 95%CI: 0.30~2.81; p&lt;0.001; see <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>), and VAS-pain scale (random-effect model; MD: 3.70; 95%CI: 1.97~5.44; p&lt;0.001; see <xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>) were all significantly improved at the final follow-up.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Forest plots for the comparisons between pre-operative and post-operative ABI <bold>(A)</bold>, skin temperature <bold>(B)</bold>, and VAS <bold>(C)</bold> in TTT group. Random-effect model was selected for the three comparisons. TTT, transverse tibia bone transportation, ABI, ankle brachial index, VAS, visual analogue scale, MD, mean difference, pre-op, pre-operative; post-op, post-operative.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1095361-g003.tif"/>
</fig>
<p>When compared with non-TTT group, the TTT group was associated with higher healing rate (OR: 10.43; 95%CI: 3.96~27.43; p&lt;0.001; see <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>) and limb salvage rate (OR: 9.65; 95%CI: 3.30~28.20; p&lt;0.001; see <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>) as shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>.</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Forest plots for the comparisons of healing rate <bold>(A)</bold> and limb salvage rate <bold>(B)</bold> between TTT and non-TTT group. TTT, transverse tibia bone transportation.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1095361-g004.tif"/>
</fig>
<p>Concerning the complications of the TTT process, (1) the pooled risk of fracture at the transportation site was 0.02 (95%CI: 0.00~0.04; see <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>); (2) the pooled pin-site infection incidence was 0.08 (95%CI: 0.00~0.22; see <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>); (3) the DFU recurrence rate in TTT group was significantly lowered comparing to that of the non-TTT group (RR: 0.18; 95%CI: 0.06~0.49; p=0.001; see <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Forest plots for the risks of fracture at transportation site <bold>(A)</bold>, and pin-site infection <bold>(B)</bold> in the TTT group, and comparison of DFU recurrence rate <bold>(C)</bold> between TTT and non-TTT group. TTT, transverse tibia bone transportation, RR, risk ratio.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-13-1095361-g005.tif"/>
</fig>
</sec>
<sec id="s3_5">
<title>Sensitivity analysis, publication bias test and trim-and-fill method</title>
<p>The forest plot of sensitivity analysis for healing rate in TTT group is presented in <xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure S1</bold>
</xref>. One study (Yuan et&#xa0;al. (<xref ref-type="bibr" rid="B17">17</xref>)) was found to cause instability on the pooling result, thus it was omitted from the final pooling (see the final forest plot in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<p>The forest plot of sensitivity analysis for limb salvage rate in TTT group is presented in <xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Figure S2</bold>
</xref>. There was no study was found to cause instability on the pooling result. Significant publication bias was detected according to Egger&#x2019;s (p = 0.019) and Begg&#x2019;s test (p = 0.327). Thus, non-parameter trim-and-fill method was performed to adjust the bias (see <xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Figure S3</bold>
</xref>), in which three studies were filled. The adjusted effect size was 0.99 (95%CI: 0.96~1.00).</p>
<p>The forest plot of sensitivity analysis for mean healing time in TTT group is presented in <xref ref-type="supplementary-material" rid="SF4">
<bold>Supplementary Figure S4</bold>
</xref>. There was no study was found to cause instability on the pooling result. No significant publication bias was detected according to Egger&#x2019;s (p = 0.125) and Begg&#x2019;s test (p = 0.624).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>The main findings of the current systematic review include TTT was associated with higher healing rate and limb salvage rate when compared with control group; following operation the ABI, skin temperature, and VAS pain scale were all significantly improved; concerning the safety aspect, the TTT was associated with relatively low risks of fracture at transportation site (2%), pin-site infection (8%) and DFU recurrence (2.9%).</p>
<sec id="s4_1">
<title>The effectiveness of TTT procedure</title>
<p>In patients with diabetic foot, the peripheral neuropathy and vascular disease are frequently encountered, which would develop to ulceration and even amputation. The DFU, as a terminal complication of the diabetes, is of quite complex pathogenesis, being derived from a combined action of ischemia, mechanical injury, infection, and so on. Usually, the ischemia and hypoxia status is caused by damage of the small blood vessels which could not be rescued by vascular surgery (<xref ref-type="bibr" rid="B21">21</xref>). TTT, as a novel developed technique which was based on the Ilizarov tension-stress law, has been recently used for treatment for DFU patients with primarily satisfied success rate (<xref ref-type="bibr" rid="B18">18</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>). These studies demonstrated that repeated mechanical stretching of the tibia bone block could stimulate the regeneration of blood vessel and accelerate the ulceration healing.</p>
<p>Yang et&#xa0;al. (<xref ref-type="bibr" rid="B22">22</xref>) explored the biological mechanism of the TTT procedure in rat model, and demonstrated that TTT was associated with higher blood flow in the wound area according to laser speckle imaging, and enhanced neovascularization according to double immune-labelling of CD31 and &#x3b1;-Smooth Muscle Actin (&#x3b1;-SMA). Previous studies have shown that bone distraction could enhance neovascularization through a pathway involving chemokine stromal cell-derived factor-1 (SDF-1), which is a key factor responsible for homing and migration of endothelial progenitor cells (<xref ref-type="bibr" rid="B23">23</xref>). In a case-control study by Chen et&#xa0;al. (<xref ref-type="bibr" rid="B19">19</xref>), they compared the treatment outcome of severe and recalcitrant DFUs with TTT and solitary standard operation, showing that tibial transverse distraction group had higher healing rate, limb salvage rate, density of small vessels, blood flow and blood volume, compared with the control group. In our results, the healing rate and limb salvage rate were demonstrated to be as high as 96% and 98% at final follow-up, and significant improvements on ABI (MD = 0.23), skin temperature (MD = 1.56) and VAS (MD = 3.70) were identified. When compared with control group, the healing rate (OR = 10.43) and limb salvage rate (OR = 9.65) were both obviously increased. These findings all confirmed the acceleration effect on neovascularization. The ABI and skin temperature is directly related with the microcirculatory perfusion of foot soft tissue. With an improved blood perfusion, sufficient oxygen and nutrition supplies can be guaranteed for ulceration healing.</p>
<p>However, though TTT was proven to be effective in promote ulceration healing, DFU is a multi-disciplinary condition which is difficult to be completely solved by sole TTT operation (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). Many assistance procedures were applied at the same time, including debridement of the ulceration lesion (<xref ref-type="bibr" rid="B15">15</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>), antibiotic bone cement filling (<xref ref-type="bibr" rid="B16">16</xref>), and vacuum sealing drainage (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B20">20</xref>), which have all been proven to be valuable in promoting healing of ulcer wounds. At the peri-operative period, blood sugar controlling is the basic requirement to guarantee a hypoglycaemic condition for tissue repairing. Antibiotics (intravenous or per oral) according to drug sensitivity testing is also essential to control the infection and ensure the healing process. It had been reported that adequate foot care can prevent 80% of DFUs in diabetes patients (<xref ref-type="bibr" rid="B26">26</xref>) and effectively prevent amputation caused by ulcerations (<xref ref-type="bibr" rid="B27">27</xref>). Thus, it is of importance to continue standard wound care (dressing changing and disinfection) and off-loading casts in peri-operative period.</p>
</sec>
<sec id="s4_2">
<title>The safety of TTT procedure</title>
<p>The procedure of TTT, however, is related with some potential complications, especially the fracture at the tibial bone window (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>), infection of the pin site (<xref ref-type="bibr" rid="B15">15</xref>, <xref ref-type="bibr" rid="B19">19</xref>) and skin necrosis at surgical site (<xref ref-type="bibr" rid="B10">10</xref>). Our results showed a total of 5 tibia fracture among 178 patients (pooled proportion: 2%), and 8 pin-site infections among 166 patients (pooled proportion: 8%). In Fan et&#xa0;al. (<xref ref-type="bibr" rid="B15">15</xref>), the authors suggested to avoid the fracture risk by establishing standard tibial osteotomy criteria and performing post-operative education on falling prevention. They also recommended to narrow the bone window for those patients with short stature. We firmly in favour of their proposal. Additionally, those with severe osteoporosis especially among the postmenopausal older women should be referred to standard osteoporosis treatments to prevent risk of fracture at osteotomy site. Moreover, it is of great importance to let the patients return for regular follow-up after operation. To avoid the risk of infection of pin channel, peri-operative antibiotics and daily wound care (especially pin site disinfection) are mostly important. The necrosis of local soft tissue is another major concerning during TTT, which is mainly caused by long-term continuous pressure on the skin overlying the anterior tibia (<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>). The surgeons should try their best to preserve the blood supply of the skin flap and avoid excessive interference to the soft tissue. Post-operatively, close attention should be applied on the skin status, and termination of transportation is indicated if signs of ischemia or necrosis are evident.</p>
<p>In 2020, with the concerted efforts of experts in various disciplines, the &#x201c;Expert Consensus on the Treatment of Diabetic Foot Ulcers Using Tibial Transverse Transport&#x201d; (<xref ref-type="bibr" rid="B30">30</xref>) was published in China. It has emphasized the importance of further simplification of the external fixator aiming to reduce the risk of complications. During the operation period, tourniquet should not be applied, to protect the blood supply of lower limb. It is of vital significance to narrow the incision and bone window sizes and preserve the periosteum, as far as possible. Through these strategies, incidence of adverse events could be significantly reduced without addition on the difficulty of surgery process.</p>
</sec>
</sec>
<sec id="s5">
<title>Limitation</title>
<p>This study, nevertheless, has some limitations that must be pointed out here. Firstly, as the TTT technique was applied for DFU treatment in the most recent years, the available publications in this field are scarce with generally small sample size and retrospective design. Thus, more prospective studies with larger sample size are required in the future. Then, since the TTT procedure is predominately conducted in China, data from non-Chinese patients are not available at this stage. Thus, some further studies are required to verify the effectiveness of this operation in patients around the world.</p>
</sec>
<sec id="s6" sec-type="conclusions">
<title>Conclusions</title>
<p>The TTT operation was demonstrated to be with high healing rate and limb salvage rate, and could significantly improve the ABI, skin temperature, and VAS after operation. When compared with the control group, TTT group provided significantly higher healing rate and limb salvage rate. However, TTT operation should be conducted with caution concerning the incidences of fracture at tibia, infection at pin channels and necrosis of skin overlying the anterior tibia.</p>
</sec>
<sec id="s7" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>X-XH and Z-ZX contributed equally to this study. X-XH, Z-ZX, and G-CL: methodology, validation, formal analysis, data extraction, data curation, writing-original draft, writing-reviewing and editing, and project administration. J-YZ, L-JS, and ZC: investigation, and data processing. X-XH and HL: validation, writing-reviewing and editing. Q-FZ, and QZ: project administration. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2022.1095361/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2022.1095361/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.doc" id="SM1" mimetype="application/msword"/>
<supplementary-material xlink:href="DataSheet_2.doc" id="SM2" mimetype="application/msword"/>
<supplementary-material xlink:href="DataSheet_3.doc" id="SM3" mimetype="application/msword"/>
<supplementary-material xlink:href="Image_1.tif" id="SF1" mimetype="image/tiff"/>
<supplementary-material xlink:href="Image_2.tif" id="SF2" mimetype="image/tiff"/>
<supplementary-material xlink:href="Image_3.tif" id="SF3" mimetype="image/tiff"/>
<supplementary-material xlink:href="Image_4.tif" id="SF4" mimetype="image/tiff"/>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>TTT, Transverse Tibial Bone Transport; DFU, diabetic foot ulcerations; ABI, ankle-brachial index; VAS, visual analogue scale; IDF, International Diabetes Federation; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-analysis; CENTRAL, Cochrane Central Register of Controlled Trials; RCTs, randomized controlled trials; HbA1C, glycosylated hemoglobin; NOS, Newcastle-Ottawa scale; JBI-MAStARI, JBI Meta-Analysis of Statistics, Assessment, and Review Instrument; MD, mean difference; OR, odds ratio; RR, risk ratio; VSD, vacuum sealing drainage; ABC, antibiotic bone cement; &#x3b1;-SMA, &#x3b1;-Smooth Muscle Actin; SDF-1, stromal cell-derived factor-1.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Saeedi</surname> <given-names>P</given-names>
</name>
<name>
<surname>Karuranga</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pinkepank</surname> <given-names>M</given-names>
</name>
<name>
<surname>Ogurtsova</surname> <given-names>K</given-names>
</name>
<name>
<surname>Duncan</surname> <given-names>BB</given-names>
</name>
<etal/>
</person-group>. <article-title>IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045</article-title>. <source>Diabetes Res Clin Pract</source> (<year>2022</year>) <volume>183</volume>:<elocation-id>109119</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.diabres.2021.109119</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sorber</surname> <given-names>R</given-names>
</name>
<name>
<surname>Abularrage</surname> <given-names>CJ</given-names>
</name>
</person-group>. <article-title>Diabetic foot ulcers: Epidemiology and the role of multidisciplinary care teams</article-title>. <source>Semin Vasc Surg</source> (<year>2021</year>) <volume>34</volume>:<fpage>47</fpage>&#x2013;<lpage>53</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1053/j.semvascsurg.2021.02.006</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ou</surname> <given-names>S</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Transverse tibial bone transport enhances distraction osteogenesis and vascularization in the treatment of diabetic foot</article-title>. <source>Orthop Surg</source> (<year>2022</year>) <volume>14</volume>:<page-range>2170&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/os.13416</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armstrong</surname> <given-names>DG</given-names>
</name>
<name>
<surname>Boulton</surname> <given-names>AJM</given-names>
</name>
<name>
<surname>Bus</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>Diabetic foot ulcers and their recurrence</article-title>. <source>N Engl J Med</source> (<year>2017</year>) <volume>376</volume>:<page-range>2367&#x2013;75</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1056/NEJMra1615439</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sampath Kumar</surname> <given-names>A</given-names>
</name>
<name>
<surname>Maiya</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Shastry</surname> <given-names>BA</given-names>
</name>
<name>
<surname>Vaishali</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ravishankar</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hazari</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis</article-title>. <source>Ann Phys Rehabil Med</source> (<year>2019</year>) <volume>62</volume>:<fpage>98</fpage>&#x2013;<lpage>103</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.rehab.2018.11.001</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname> <given-names>JCN</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Wareham</surname> <given-names>NJ</given-names>
</name>
<name>
<surname>Shaw</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Orchard</surname> <given-names>TJ</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>P</given-names>
</name>
<etal/>
</person-group>. <article-title>The lancet commission on diabetes: using data to transform diabetes care and patient lives</article-title>. <source>Lancet</source> (<year>2021</year>) <volume>396</volume>:<page-range>2019&#x2013;82</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(20)32374-6</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffstad</surname> <given-names>O</given-names>
</name>
<name>
<surname>Mitra</surname> <given-names>N</given-names>
</name>
<name>
<surname>Walsh</surname> <given-names>J</given-names>
</name>
<name>
<surname>Margolis</surname> <given-names>DJ</given-names>
</name>
</person-group>. <article-title>Diabetes, lower-extremity amputation, and death</article-title>. <source>Diabetes Care</source> (<year>2015</year>) <volume>38</volume>:<page-range>1852&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/dc15-0536</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geraghty</surname> <given-names>T</given-names>
</name>
<name>
<surname>LaPorta</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Current health and economic burden of chronic diabetic osteomyelitis</article-title>. <source>Expert Rev Pharmacoecon Outcomes Res</source> (<year>2019</year>) <volume>19</volume>:<page-range>279&#x2013;86</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/14737167.2019.1567337</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ilizarov</surname> <given-names>GA</given-names>
</name>
</person-group>. <article-title>The tension-stress effect on the genesis and growth of tissues. part i. the influence of stability of fixation and soft-tissue preservation</article-title>. <source>Clin Orthop Relat Res</source> (<year>1989</year>) <volume>238)</volume>:<page-range>249&#x2013;81</page-range>.</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>YK</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>DP</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Twenty years development of tibial cortex transverse transport surgery in PR China</article-title>. <source>Orthop Surg</source> (<year>2022</year>) <volume>14</volume>:<page-range>1034&#x2013;48</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/os.13214</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nickinson</surname> <given-names>ATO</given-names>
</name>
<name>
<surname>Houghton</surname> <given-names>JSM</given-names>
</name>
<name>
<surname>Bridgwood</surname> <given-names>B</given-names>
</name>
<name>
<surname>Essop-Adam</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nduwayo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Payne</surname> <given-names>T</given-names>
</name>
<etal/>
</person-group>. <article-title>The utilisation of vascular limb salvage services in the assessment and management of chronic limb-threatening ischaemia and diabetic foot ulceration: A systematic review</article-title>. <source>Diabetes Metab Res Rev</source> (<year>2020</year>):<elocation-id>e3326</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/dmrr.3326</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>C</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>[Research progress of tibial transverse transport in treatment of chronic ischemic diseases of the lower extremities]</article-title>. <source>Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi</source> (<year>2020</year>) <volume>34</volume>:<page-range>994&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7507/1002-1892.202004061</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qu</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>[The therapy of transverse tibial bone transport and vessel regeneration operation on thromboangitis obliterans]</article-title>. <source>Zhonghua Yi Xue Za Zhi</source> (<year>2001</year>) <volume>81</volume>:<page-range>622&#x2013;4</page-range>.</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nie</surname> <given-names>X</given-names>
</name>
<name>
<surname>Kuang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Tibial cortex transverse transport facilitating healing in patients with recalcitrant non-diabetic leg ulcers</article-title>. <source>J Orthop Translat</source> (<year>2020</year>) <volume>27</volume>:<fpage>1</fpage>&#x2013;<lpage>7</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jot.2020.11.001</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>ZQ</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>ZH</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>JZ</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>BF</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>DW</given-names>
</name>
</person-group>. <article-title>Tibial cortex transverse distraction in treating diabetic foot ulcers: what are we concerned about</article-title>? <source>J Int Med Res</source> (<year>2020</year>) <volume>48</volume>:<elocation-id>300060520954697</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/0300060520954697</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname> <given-names>X</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ji</surname> <given-names>K</given-names>
</name>
<name>
<surname>Lv</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Analysis of the effect of antibiotic bone cement in the treatment of diabetic foot ulcer through tibia transverse transport</article-title>. <source>Orthop Surg</source> (<year>2022</year>) <volume>14</volume>:<page-range>2141&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/os.13412</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>X</given-names>
</name>
<name>
<surname>Jing</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Modified tibial transverse transport technique for the treatment of ischemic diabetic foot ulcer in patients with type 2 diabetes</article-title>. <source>J Orthop Translat</source> (<year>2021</year>) <volume>29</volume>:<page-range>100&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jot.2021.04.006</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Kuang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Li</surname> <given-names>K</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Computed tomography perfusion study evaluating the curative effect of tibial transverse transport in patients with severe diabetic foot</article-title>. <source>J Orthop Translat</source> (<year>2019</year>) <volume>19</volume>:<page-range>133&#x2013;42</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jot.2019.04.005</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Kuang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhen</surname> <given-names>P</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Proximal tibial cortex transverse distraction facilitating healing and limb salvage in severe and recalcitrant diabetic foot ulcers</article-title>. <source>Clin Orthop Relat Res</source> (<year>2020</year>) <volume>478</volume>:<page-range>836&#x2013;51</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/CORR.0000000000001075</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname> <given-names>ZQ</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>DW</given-names>
</name>
</person-group>. <article-title>Impairment characteristics of static balance and plantar load distribution of patients undergoing tibial cortex transverse distraction for diabetic foot ulcers</article-title>. <source>J Orthop Surg Res</source> (<year>2022</year>) <volume>17</volume>:<fpage>171</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13018-022-03042-3</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arora</surname> <given-names>S</given-names>
</name>
<name>
<surname>Pomposelli</surname> <given-names>F</given-names>
</name>
<name>
<surname>LoGerfo</surname> <given-names>FW</given-names>
</name>
<name>
<surname>Veves</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization</article-title>. <source>J Vasc Surg</source> (<year>2002</year>) <volume>35</volume>:<page-range>501&#x2013;5</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1067/mva.2002.121126</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>XH</given-names>
</name>
<etal/>
</person-group>. <article-title>Tibial cortex transverse transport accelerates wound healing <italic>via</italic> enhanced angiogenesis and immunomodulation</article-title>. <source>Bone Joint Res</source> (<year>2022</year>) <volume>11</volume>:<page-range>189&#x2013;99</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1302/2046-3758.114.BJR-2021-0364.R1</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>J</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Stromal cell-derived factor-1 may play pivotal role in distraction-stimulated neovascularization of diabetic foot ulcer</article-title>. <source>Med Hypotheses</source> (<year>2021</year>) <volume>149</volume>:<elocation-id>110548</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mehy.2021.110548</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rayman</surname> <given-names>G</given-names>
</name>
<name>
<surname>Vas</surname> <given-names>P</given-names>
</name>
<name>
<surname>Dhatariya</surname> <given-names>K</given-names>
</name>
<name>
<surname>Driver</surname> <given-names>V</given-names>
</name>
<name>
<surname>Hartemann</surname> <given-names>A</given-names>
</name>
<name>
<surname>Londahl</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Guidelines on use of interventions to enhance healing of chronic foot ulcers in diabetes (IWGDF 2019 update)</article-title>. <source>Diabetes Metab Res Rev</source> (<year>2020</year>) <volume>36 Suppl 1</volume>:<elocation-id>e3283</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/dmrr.3283</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chuter</surname> <given-names>V</given-names>
</name>
<name>
<surname>Quigley</surname> <given-names>F</given-names>
</name>
<name>
<surname>Tosenovsky</surname> <given-names>P</given-names>
</name>
<name>
<surname>Ritter</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Charles</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cheney</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Australian Guideline on diagnosis and management of peripheral artery disease: part of the 2021 Australian evidence-based guidelines for diabetes-related foot disease</article-title>. <source>J Foot Ankle Res</source> (<year>2022</year>) <volume>15</volume>:<fpage>51</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13047-022-00550-7</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kavitha</surname> <given-names>KV</given-names>
</name>
<name>
<surname>Tiwari</surname> <given-names>S</given-names>
</name>
<name>
<surname>Purandare</surname> <given-names>VB</given-names>
</name>
<name>
<surname>Khedkar</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bhosale</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Unnikrishnan</surname> <given-names>AG</given-names>
</name>
</person-group>. <article-title>Choice of wound care in diabetic foot ulcer: A practical approach</article-title>. <source>World J Diabetes</source> (<year>2014</year>) <volume>5</volume>:<page-range>546&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4239/wjd.v5.i4.546</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Crawford</surname> <given-names>F</given-names>
</name>
<name>
<surname>Inkster</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kleijnen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fahey</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Predicting foot ulcers in patients with diabetes: a systematic review and meta-analysis</article-title>. <source>QJM</source> (<year>2007</year>) <volume>100</volume>:<fpage>65</fpage>&#x2013;<lpage>86</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/qjmed/hcl140</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>XZ</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Jing</surname> <given-names>DM</given-names>
</name>
</person-group>. <article-title>[Vessel regeneration by tibial bone immigration on the thromboangiitis obliterans: an analysis of 35 cases]</article-title>. <source>Zhongguo Shi Yong Wai Ke Za Zhi</source> (<year>2011</year>) <volume>31</volume>:<page-range>523&#x2013;4</page-range>.</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>D</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>B</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>[Analysis of complications in diabetic foot treated with tibial transverse transport]</article-title>. <source>Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi</source> (<year>2020</year>) <volume>34</volume>:<page-range>985&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7507/1002-1892.202003114</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Li</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>[Expert consensus on the treatment of diabetic foot ulcers using tibial transverse transport]</article-title>. <source>Zhong Guo Xiu Fu Chong Jian Wai Ke Za Zhi</source> (<year>2020</year>) <volume>34</volume>:<page-range>945&#x2013;50</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7507/1002-1892.202003046</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>